Firebrick Pharma Requests Trading Halt
Key points
- Firebrick Pharma requests trading halt pending announcement
- Halt to remain in place until earlier of Thursday, June 26 or announcement release
- Company not aware of any reason why trading halt should not be granted
Full summary
Firebrick Pharma Ltd (ASX:FRE) has requested an immediate trading halt on its securities pending the release of an announcement regarding a share placement. The trading halt will remain in place until the earlier of the commencement of normal trading on Thursday, June 26, 2025, or the release of the relevant announcement to the market. Firebrick Pharma has stated that it is not aware of any reason why the trading halt request should not be granted, and that there is no other information necessary to inform the market about the trading halt.
Summary generated by a large language model. Please interpret with care.